Infection prophylaxis

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
J Anti-infectives (ATC J) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Immunoglobulin 1 substance
Supportive / diluent 1 substance
Phase III: 1 Phase IV: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Octapharma Pharmazeutika Produktionsgesellschaft mbH Commercial
    HUMAN NORMAL IMMUNOGLOBULIN; SODIUM CHLORIDE
    2025-522854-37-00 8 countries n=215
    Pending

Phase IV

1 trial
  • Assistance Publique Hopitaux De Paris Academic
    IMP not specified
    2025-521988-13-00 1 country n=10
    Not authorised
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Octapharma Pharmazeutika Produktionsgesellschaft mbH Commercial 1 Phase III 0
Assistance Publique Hopitaux De Paris Academic 1 Phase IV 0
← All indication landscapes